Pulnovo
New York, United States · Founded 2013 · $200.0M raised
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Website
- pulnovomed.us
- Total Funding
- $200.0M
- Last Round
- $100.0M Corporate RoundApr 2026
- Rounds
- 4
About
Pulnovo Medical Limited is a globally recognized medical device pioneer in the treatment of pulmonary hypertension and heart failure. Established in 2013 and headquartered in New York, the company operates internationally with offices in Shanghai and Singapore. Pulnovo is committed to advancing innovation in pulmonary arterial hypertension and related cardiac conditions through novel device-based therapies.
Summary
Pulnovo is a Healthcare company based in New York, United States, founded in 2013. It has raised $200.0M in total across 4 rounds, most recently a $100.0M Corporate Round round in Apr 2026. Investors include Gaorong Capital, OrbiMed and Lilly Asia Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
China's leading blood products manufacturer
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...